US FDA accepts cell-based potency test for Botox
[page_title] California-based Allergan, Inc. has had its in-vitro, cell-based assay for testing the stability and potency of Botox and Botox cosmetic, approved by the FDA. Allergan has claimed that the use of the new assay will reduce the use of animal testing by up to an estimated 95 percent, over the course of the next […]
ECHA releases report on use of non-animal methods & testing strategies under REACH
[page_title] The European Chemicals Agency has published two major reports on the working of REACH and CLP Regulations and on the implementation and use of non-animal test methods and testing strategies. Video interviews with ECHA senior personnel can also be viewed online. Read more
Commission publishes stakeholder input on implementation date for animal-tested cosmetics marketing ban
[page_title] The European Commission has published inputs received from stakeholders in response to its targeted consultation concerning the proposed 2013 implementation date for an EU marketing ban for cosmetics containing ingredients tested on animals. Read more
Call for submissions for EPAA 3Rs communication prize
[page_title] Deadline: 5 September 2011. EPAA is offering a €3000 prize for an essay or article that broadens awareness of the importance to promote alternative approaches in safety assessment and regulatory compliance testing. As this year the EPAA’s lead theme is ”Integrated Testing Strategies (ITS) and their impact on the implementation of the 3Rs” the […]
ecopa participates in new ECVAM Stakeholder Forum
[page_title] ecopa has been selected by the European Centre for the Validation of Alternative Methods to be represented on the newly constituted ECVAM Stakeholder Forum (ESTAF) by board member and 3Rs expert Troy Seidle. As announced in the January newsletter, ESTAF has been established to bring together ECVAM stakeholders who operate at EU-level to promote […]
May 2011 updates from carcinoGENOMICS, ESNATS and Sens-it-iv
[page_title] ecopa is dissemination partner in the EU 6th and 7th Framework Programme projects carcinoGENOMICS, ESNATS and Sens-it-iv. Brief updates from these projects are provided below. At the 15 March board meeting it was confirmed that the carcinoGENOMICS project will be extended by an additional six months. As part of its dissemination strategy, the project […]
ECVAM/EPAA vaccine consistency workshop flash report
[page_title] A joint ECVAM/EPAA workshop discussed the applicability of the consistency approach for routine release of human and veterinary vaccines and how this could reduce animal use. The workshop was held on 11-12 January 2010, in Brussels. Flash report
EC-industry project aims to develop non-animal methods for repeated dose toxicity testing
[page_title] 1-3 March marked the official kick-off of the €50 million European Commission-COLIPA ‘Safety Evaluation Ultimately Replacing Animal Testing’ (SEURAT) programme aimed at replacement of current repeated dose systemic toxicity testing in human safety assessment. The meeting brought together the coordinators of the seven new large-scale and projects, as well as the leaders of ongoing […]
January 2011 updates from carcinoGENOMICS, ESNATS and Sens-it-iv
[page_title] ecopa is dissemination partner in the EU 6th and 7th Framework Programme projects carcinoGENOMICS, ESNATS and Sens-it-iv. Brief updates from these projects are provided below. The annual carcinoGENOMICS consortium meeting took place in Arona, Italy on 8-10 November 2010. The British Toxicology Society (BTS) is organising a workshop in conjunction with its annual congress […]
28th workshop of SSCT and the FINCOPA seminar: Towards toxicity assessment without animals
[page_title] 21-23 September 2011 Tampere, FI Read more